| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.551 | 2.463 | 1.918 | 2.369 | 2.904 | 2.685 | 2.487 | 2.366 | 2.814 | 11.015 |
| Total Income - EUR | 2.551 | 2.463 | 1.918 | 2.369 | 2.904 | 2.685 | 2.487 | 2.366 | 2.814 | 11.031 |
| Total Expenses - EUR | 2.522 | 2.103 | 1.632 | 1.983 | 2.383 | 2.169 | 1.974 | 1.852 | 2.131 | 8.634 |
| Gross Profit/Loss - EUR | 29 | 359 | 286 | 387 | 521 | 516 | 513 | 514 | 682 | 2.396 |
| Net Profit/Loss - EUR | -48 | 285 | 228 | 315 | 434 | 435 | 438 | 443 | 573 | 2.021 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Saban Intermed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 89 | 88 | 86 | 85 | 83 | 82 | 80 | 80 | 80 | 79 |
| Current Assets | 5.612 | 6.209 | 6.363 | 5.747 | 7.561 | 8.938 | 9.179 | 10.943 | 16.149 | 18.389 |
| Inventories | 5.503 | 6.153 | 6.240 | 5.649 | 7.513 | 8.612 | 8.913 | 10.892 | 16.072 | 18.061 |
| Receivables | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 0 |
| Cash | 64 | 12 | 79 | 55 | 6 | 285 | 225 | 11 | 36 | 328 |
| Shareholders Funds | 991 | 1.266 | 1.473 | 1.761 | 2.161 | 2.555 | 2.937 | 3.389 | 3.951 | 5.950 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.711 | 5.031 | 4.976 | 4.070 | 5.483 | 6.465 | 6.321 | 7.635 | 12.277 | 12.518 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Saban Intermed S.r.l.